‘COVID-friendly’ cancer care at home extended for more patients
Thousands of people with cancer can benefit from ‘COVID friendly’ treatments from home, the NHS announced today.
More than 30 different drugs are available to treat patients, offering benefits such as fewer hospital visits or a reduced impact on their immune system.
Around 8,000 people have already benefitted from the treatment ‘swaps’ since April helping to maintain cancer treatment in the face of coronavirus with more than 250,000 people starting treatment for cancer since the start of the pandemic.
The NHS is funding effective and less risky treatment ‘swaps’ for patients during the pandemic, and patient access to these drugs will now be extended until the summer, with the potential to extend until the end of March next year.
Targeted hormone therapies such as enzalutamide for prostate cancer and broadened use of lenalidomide in the treatment of myeloma – bone marrow cancer – are among the options available for clinicians to choose from.
For ovarian cancer, some patients can receive trametinib as a tablet alternative to chemotherapy and so reduce the impact on their immune systems.
The NHS Long Term Plan committed to using cutting edge treatment and technology to save and improve patients’ lives.
The COVID-friendly cancer treatments are among a string of NHS innovations that have helped patients to access treatment safely throughput the pandemic.
The NHS also made up to 10,000 chemo deliveries to patients’ doorsteps during the first wave of the virus, introduced COVID-secure surgery hubs and fast tracked stereotactic ablative radiotherapy (SABR) which requires five doses rather than up to 30 with standard radiotherapy, cutting the number of hospital visits that potentially vulnerable cancer patients need to make.
NHS England has also introduced new ways of testing patients for cancer including by piloting mini cameras that patients can swallow to test for bowel cancer.
Professor Peter Johnson, NHS clinical director for cancer said: “Cancer has been a priority throughout the pandemic which is why NHS staff have fast-tracked patient access to more convenient and kinder treatments to provide as many people as possible with safe and effective care, even as the NHS cared for more than 380 000 people seriously ill with Covid.
“Extending the use of ‘Covid friendly’ treatments for cancer is another example of how we are embracing the full range of treatment options and bringing the NHS to patients at home in many cases.
“If you have a worrying symptom, please do come forward and get checked – the NHS is ready and here to treat you. Cancer is easier to treat when it’s caught at an earlier stage and coming forward for a check could save your life.”
Recent analysis showed that when NHS England introduced the new cancer therapies, it boosted the number of people having cancer treatments during the pandemic, when treatment might otherwise have been delayed or not safe to give at all.
Treatment options also include:
- Venetoclax in acute myeloid leukaemia as an oral alternative to more toxic standard chemotherapy
- Nivolumab or pembrolizumab for patients with bowel cancer whose cancers have a specific genetic fingerprint
- Ixazomib in myeloma as an oral alternative to treatment which would require more hospital visits and injections
- Atezolizumab as first-line immunotherapy for bladder cancer instead of chemotherapy.
The NHS put in place a £160 million initiative last year so that people with cancer could benefit from alternative, more covid friendly treatments.
Annwen Jones OBE, Chief Executive of Target Ovarian Cancer, said: “This flexible approach to access to cancer drugs is to be welcomed, particularly during a global pandemic. It ensures that women with a rare type of ovarian cancer have access to the best possible treatments for them, bringing hope to a lot of families at a very difficult time.”
Latest News from
NHS sees record number of people in March, following urgent cancer referrals14/05/2021 09:15:00
Hard working NHS staff saw a record number of people, who were referred for urgent cancer checks, in March, new figures have revealed.
NHS’s £160 million ‘accelerator sites’ to tackle waiting lists13/05/2021 11:25:00
The NHS has today announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the health service is recovering faster after the second wave of the coronavirus pandemic.
NHS in England hits 45 million vaccinations12/05/2021 16:10:00
Today the NHS in England marks another important milestone, delivering more than 45 million vaccinations.
Thousands of new recruits join the health service as NHS marks International Nurses Day12/05/2021 11:20:00
NHS chief Sir Simon Stevens has today praised the ‘extraordinary’ response of nurses and healthcare workers to COVID as the so-called ‘Nightingale effect’ sees thousands of new NHS recruits mark their first International Nurses Day.
Second dose milestone as one third of adults in England receive both jabs11/05/2021 09:15:00
The NHS in England has confirmed that one third of adults in England have now had both doses of the COVID-19 vaccine.
More than a million children given access to NHS mental health support at school10/05/2021 13:15:00
More than a million children and young people will have access to mental health support at school, as the NHS rapidly expands services to help deal with the huge disruption caused by coronavirus and lockdown.
NHS to offer new drug that halves the risk of cancer returning07/05/2021 14:15:00
A world-leading treatment that halves the risk of lung cancer patients suffering a return of the disease after undergoing treatment, is to be rolled out by NHS England.
3D heart scans on the NHS to speed up disease diagnosis05/05/2021 09:15:00
The NHS is rolling out revolutionary technology to diagnose and treat around 100,000 patients with suspected heart disease, five times faster than normal.